Trials / Completed
CompletedNCT02235480
Efficacy and Safety of Tazarotene Gel in Nail Psoriasis
A Phase II Trial to Evaluate the Anti-psoriatic Efficacy and Tolerability of Tazarotene in a Gel Formulation in Patients With Mild to Moderate Nail Psoriasis - Parallel Group Comparison
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- Almirall, S.A. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to determine the efficacy and safety of topical application of the gel compared to placebo in nail psoriasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Experimental Tazarotene Gel | |
| DRUG | Placebo |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2014-05-01
- Completion
- 2015-05-01
- First posted
- 2014-09-10
- Last updated
- 2015-06-10
Locations
4 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT02235480. Inclusion in this directory is not an endorsement.